San Francisco, California -- Medical marijuana technology company Eaze has secured $8.3 million in its second round of institutional venture capital financing, according to an SEC regulatory filing.
Eaze "helps patients receive medical marijuana in California from dispensaries."
Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.
A total of six investors participated in the offering.
Eaze is still seeking $22 million in additional equity venture capital investment, according to the filing.